Magnetic Solid-Phase Microextraction Protocol Based on Didodecyldimethylammonium Bromide-Functionalized Nanoparticles for the Quantification of Epirubicin in Biological Matrices.

drug monitoring epirubicin magnetic solid-phase microextraction nanoparticles validation

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
12 Apr 2023
Historique:
received: 15 03 2023
revised: 30 03 2023
accepted: 11 04 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Due to epirubicin's (EPI) narrow therapeutic index and risk of cardiotoxicity, it is critical to monitor concentrations of this drug when being used to treat cancer patients. In this study, a simple and fast magnetic solid-phase microextraction (MSPME) protocol for the determination of EPI in plasma and urine samples is developed and tested. Experiments were performed using prepared Fe

Identifiants

pubmed: 37111712
pii: pharmaceutics15041227
doi: 10.3390/pharmaceutics15041227
pmc: PMC10145736
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : the European Union through the Eu-ropean Social Fund under the Operational Programme Knowledge Education Development 2014-2020.
ID : POWR.03.02.0 0-0 0- I014/17-00

Références

J Colloid Interface Sci. 2016 Sep 15;478:365-73
pubmed: 27318715
J Sep Sci. 2010 Jun;33(11):1571-9
pubmed: 20437415
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3543-8
pubmed: 19783235
Ther Drug Monit. 2003 Aug;25(4):433-40
pubmed: 12883225
Acta Oncol. 2021 Jul;60(7):954-956
pubmed: 33783307
J Chromatogr A. 2016 Jul 8;1454:1-8
pubmed: 27266334
Crit Rev Anal Chem. 2021 Nov 24;:1-14
pubmed: 34818953
Anal Bioanal Chem. 2018 Jun;410(16):3779-3788
pubmed: 29658094
Molecules. 2020 Apr 09;25(7):
pubmed: 32283595
Breast Cancer Res. 2011 Jun 09;13(3):R57
pubmed: 21658222
Oncologist. 2019 Jun;24(6):e394-e396
pubmed: 30846514
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:24-30
pubmed: 30927739
Pharmaceutics. 2021 Nov 16;13(11):
pubmed: 34834357
Int J Gynecol Cancer. 2015 Jul;25(6):977-84
pubmed: 25962114
Clin Pharmacol Ther. 2019 Mar;105(3):598-613
pubmed: 29923599
Anal Chem. 2022 Dec 6;94(48):16587-16595
pubmed: 36413572
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3907-15
pubmed: 19828385
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 1;1136:121910
pubmed: 31830661

Auteurs

Natalia Treder (N)

Department of Analytical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.
Department of Pharmaceutical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Natalia Szuszczewicz (N)

Department of Analytical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Anna Roszkowska (A)

Department of Pharmaceutical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Ilona Olędzka (I)

Department of Pharmaceutical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Tomasz Bączek (T)

Department of Pharmaceutical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Ewa Bień (E)

Department of Pediatrics, Hematology and Oncology, Medical University Gdansk, 80-211 Gdansk, Poland.

Małgorzata Anna Krawczyk (MA)

Department of Pediatrics, Hematology and Oncology, Medical University Gdansk, 80-211 Gdansk, Poland.

Alina Plenis (A)

Department of Analytical Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland.

Classifications MeSH